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Ca2+ handling in intact sinoatrial node in a mice model of catechola-
minergic polymorphic ventricular tachycardia
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Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a
lethal genetic disease characterized by exercise/stress-induced syncope
and/or sudden death in young individuals with structurally normal hearts.
More than 150 identified mutations located in the cardiac Ca2+ release
channel (type-2 ryanodine receptor, RyR2) gene are related to CPVT.
Besides ventricular tachycardia sinoatrial node (SAN) dysfunction is fre-
quently observed in CPVT patients. However, the cellular mechanism
remains unknown. Here we analysed intracellular Ca2+ handling in SAN
dissected from mice bearing a mutation in RyR2 found in CPVT patients
(RyR2R420Q) and compared to wild type littermates (WT). Animals were
implanted with Holter telemetry captors. One week after surgery, ECGs
were recorded in basal conditions and after epinephrine/caffeine injection
(2/120 mg/kg). All RyR2R420Q mice presented sustained bidirectional
ventricular tachycardia, characteristic of CPVT, thus validating the model.
SAN were dissected, loaded with the fluorescence Ca2+ dye Fluo-4 and
spontaneous Ca2+ variations viewed with by confocal microscopy using a
white light laser and resonant scanning. The cycle length of spontaneous
[Ca2+]i transients was significant longer in RYR2R420Q mice, but
[Ca2+]i transient amplitudes were similar between RyR2R420Q and WT.
Besides [Ca2+]i sparks in each spontaneous beats was also longer in
RYR2R420Q mice. Addition of 20 nM isoprenaline dramatically increased
the heart rate in both RYR2R420Q and WT SAN, but the effect was pro-
portionally higher in RyR2R420Q SAN. Thus, our research shows that
RYR2R420Q SAN mutation: 1) induce CPVT phenotype in mice,
2) decreases the SAN rhythm, suggesting a SAN dysfunction, 3) has more
[Ca2+]i leak during diastole as [Ca2+]i sparks, 4) has more effect to
β adrenergic agonists, which may contribute to supraventricular
arrhythmia in CPVT.
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SCN5A+/ΔQKP mice: new model of long QT syndrome associated
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Deletion of QKP1507-1509 amino-acids in the Nav1.5 voltage-gated
Na+ channel is associated with a large phenotypic spectrum of LQT3,
conduction disorder, dilated cardiomyopathy (DCM) and high incidence of
youth sudden death. This mutation does not affect the peak Na+ current
but rather increases the late Na+ current. In order to identify the mecha-
nism of DCM in these patients, a knock-in mouse model presenting the
equivalent to human QKP1507-1509 mutation, has been generated
(Scn5a+/ΔQKP).
Four groups of mice were studied: wild-type (Scn5a+/+), heterozygous
flp deleter (Scn5a+/+–flp), heterozygous neomycin-ΔQKP (Scn5a+/neo)
and Scn5a+/ΔQKP mice. Six-lead ECG were recorded on 3-week-old to
10-week-old mice. Acute Ranolazine treatment (30 mg/kg) was performed
on 3-week-old mice. Action potential recording was performed on left
atrium and right ventricle of 4-week-old mice. Echocardiography and his-
tological studies were also performed on 4-week-old mice.
Scn5a+/ΔQKP mice exhibited high early mortality with 50% of death
at the age of 5-6 weeks. ECGs showed that 24/56 Scn5a+/ΔQKP exhibited
ventricular extrasystoles and/or non-sustained ventricular tachycardia.
Scn5a+/ΔQKP mice in sinus rhythm showed a prolonged QT interval (QTc
= 78±6 ms, versus 46±2 ms in controls, n=22). Atrial and ventricular
action potential recordings displayed action potential prolongation in
Scn5a+/ΔQKP mice. In 4-week-old Scn5a+/ΔQKP mice, echocardio-
graphic and histological analysis displayed cardiac diastolic dysfunction
compared to control mice with right ventricle enlargement. Ten-week-old
Scn5a+/ΔQKP mice showed signs of hypertrophic remodeling. Treatment
with Ranolazine suppressed arrhythmias and QT heterogeneity in Scn5a+/
ΔQKP mice.
Scn5a+/ΔQKP mice reproduce the phenotype of the human mutation car-
riers, i.e. long QT syndrome, heart failure and increased risk of sudden death
at a young age. We could hypothesize that part of early mortality could be
attributed to arrhythmias.
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Role of cAMP phosphodiesterases in the regulation of BK (Ca) chan-
nels in rat coronary arteries
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Objective: 3’-5’-cyclic adenosine monophosphate (cAMP) is an important
mediator of vasorelaxation. In vascular smooth muscle, subcellular cAMP
concentrations are mainly regulated by type 3 and 4 phosphodiesterases
(PDE3 & PDE4). Large conductance Ca2+-activated K+ channels (BKCa) chan-
nels are reported to mediate cAMP-induced relaxation. Here, we sought to
clarify whether BKCa channels are regulated by PDE activities in rat coronary
arteries (CA) following β-adrenergic stimulation.
Material and methods: CA were rapidly isolated from euthanized adult
male Wistar rats, cut in 2 mm length rings and mounted on a wire myograph.
Cumulative concentration-relaxation experiments were conducted on rings
contracted with the thromboxane analogue U46619 (0.1-3 μM).
Results: The BKCa inhibitor iberiotoxin (IBTX, 0.1 μM) did not alter
pD2 of isoproterenol (ISO) response. However, IBTX significantly
reduced maximal relaxation induced by ISO, from 97±0.3% to 42±0.1%
(N=10-12 animals, P<0.001). In rings without a functional endothelium,
IBTX still significantly reduced ISO maximal response (36±3%, N=5,
P<0.001) compared to vehicle (100±1%, N=6). Endothelium denudation
of rCA rings slightly reduced ISO potency compared to intact rings, and
this was observed either in the presence (N=6) or in the absence (N=5)
of IBTX. In intact rings, inhibition of PDE3 using 1 μM cilostamide
(Cil) and of PDE4 using 10 μM Ro20-1724 (Ro) increased ISO potency
(N=9, P<0.01; N=6, P< 0.001, respectively, compared to vehicle:
pD2=7.7±0.1, N=14). However, Cil and Ro were without effect in the
presence of IBTX (N=6-9).
Conclusion: These results show that, in rat CA, i) BKCa channels are
important effectors of ISO-induced relaxation; ii) BKCa-dependent component
of the response to ISO is not affected by endothelium removal; and iii) inhi-
bition of PDE3 or PDE4 potentiates the response to ISO, an effect that
requires active BKCa channels.
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The cardiac sodium channel NaV1.5 initiates the action potential (AP)
and is essential for conduction. The last three residues of NaV1.5 (Ser-Ile-
Val) constitute a PDZ domain-binding motif (SIV) that interacts with PDZ
proteins such as syntrophin proteins and SAP97 defining distinct subsets
of NaV1.5 multi-protein complexes, respectively at the lateral membrane
and the intercalated discs (ID) of cardiomyocytes. Previous results with
dystrophin-deficient mice showed that disruption of the dystrophin-syntro-
phin macromolecular complex impairs excitability and impulse propaga-
tion by reducing the expression of NaV1.5 and syntrophin at the lateral
membrane of cardiomyocytes. Recently, we investigated the in vivo role of
the NaV1.5 SIV motif by characterizing mice bearing a truncation of this
motif (ΔSIV). Western blots of ΔSIV hearts displayed reduced levels of
NaV1.5, which corresponded to a 35% decrease in cardiomyocyte whole-
cell INa and AP upstroke velocity. Immunostainings revealed a specific loss
of NaV1.5 channels in ΔSIV cardiomyocytes at lateral membranes concom-
itant to a 60% decrease in INa recorded at the lateral membrane. However,
NaV1.5 expression at ID and T-tubules was not altered. No INa decrease
was observed at the ID. Epicardial mapping of ΔSIV hearts showed
decreased conduction velocity that manifested as prolongation of the QRS
interval in ECGs. When SAP97 expression was constitutively suppressed
in the heart of knock-out mice, INa and AP maximal upstroke velocity were
unchanged. However, AP duration was greatly increased, suggesting that
the expression and function of other ion channels is modified. These data
reflect the in vivo significance of the PDZ-domain-binding SIV motif in
correct expression of NaV1.5 channels at the lateral membrane and under-
line the functional role of lateral NaV1.5 channels in cardiac conduction.
In addition, the results confirm the existence of distinct pools of
NaV1.5 channels within the cardiomyocytes and suggest a complex regula-
tion and organization of the NaV1.5 pool at the ID, where compensatory
mechanisms could be developped when SAP97 expression is constitutively
suppressed.
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phosphorylation sites on the native cardiac NAV1.5 channel protein in
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Voltage-gated Na+ (Nav) channels are key determinants of myocar-
dial excitability and defects in Nav channel functioning or regulation,
associated with inherited and acquired cardiac disease, increase the risk
of life-threatening arrhythmias. In heart failure, the inactivation gating
properties of Nav1.5 channels are altered, resulting in decreased channel
availability and increased late Na+ current. Although previous studies
have suggested roles for CaMKII- and SGK1-dependent Nav1.5 phos-
phorylation sites, the global native phosphorylation pattern of Nav1.5
channels associated with these pathophysiological alterations is
unknown. Mass spectrometric (MS)-based phosphoproteomic analyses
were undertaken to identify in situ the native phosphorylation sites on
the Nav1.5 protein purified from ventricles isolated from WT and CaM-
KIIdc-Tg mice overexpressing CaMKIIdc in the heart. Quantitative anal-
yses of Nav1.5 phosphopeptides allowed comparing the relative
abundances of Nav1.5 phosphorylation sites in CaMKIIdc-Tg, versus
WT, ventricles. A total of seventeen Nav1.5 phosphorylation sites were
identified, seven of which are novel as compared with those reported in
our previous MS analyses. Thirteen of these sites are located in the first
loop, one in the second loop, one in the N-terminus and two in the C-
terminus of Nav1.5. Interestingly, out of these seventeen phosphorylation
sites, the C-terminal phosphoserine pS1938 is present in the CaMKIIdc-Tg IPs
(n=3/4) and absent in the WT IPs (n=0/4), and pS1989 is 9-fold more
represented (p<0.05, n=4 in each condition) in the CaMKIIdc-Tg, com-
pared with the WT, IPs. Additionally, three phosphoserines at positions
483, 484 and 664 conform to the consensus phosphorylation sequence of
SGK1. These analyses (1) provide seven novel native cardiac Nav1.5
phosphorylation sites, and (2) identify five Nav1.5 phosphorylation sites
as potential critical determinants of the pathophysiological alterations of
Nav1.5 channels in heart failure.
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Endocytosis pathway of Kv1.5 channels in atrial cardiomyocytes
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Trafficking of ion channels in cardiomyocytes is a highly dynamic
process which is determinant for shaping action potential. In this study,
we focused on the dynamic of Kv1.5 channel which carry the atria-spe-
cific potassium outward current implicated in the repolarisation of the
action potential. We first investigated the endocytosis pathway for Kv1.5
channels in the atria. High resolution 3-D microscopy revealed that
Kv1.5 channels are associated with clathrin vesicles in atrial myocytes
but not with caveolin. Electron microscopy showed that vesicles are
found both at the lateral sarcolemma and at the intercalated disc.
Blockade of the clathrin pathway using hypertonic media or SiRNA
induced an increase in IKur recorded by whole-cell patch-clamp and an
accumulation of Kv1.5 channels at the sarcolemma as shown by biotinyl-
ation assay. Clathrin blockade also increased fluorescence recovery after
photobleaching of Kv1.5 channels. Altogether, these data show that
Kv1.5 channels are internalized through the clathrin pathway. Our objec-
tive now is to investigate the kinetics of Kv1.5 channel internalization in
living atrial myocytes. Total Internal Reflection Fluorescence micros-
copy approach will be used to follow eGFPKv1.5-Kv1.5 channels in
living cells and to establish their dynamic in control and clathrin-blocked
myocytes. To deplete sub-membrane stores of Kv1.5 channels, atrial
myocytes will be exposed to shear-stress and endocytosis will be fol-
lowed for 30 min. The fate of internalized channels will be investigated
at different time points by co-immunostainings with antibodies directed
against the different endosomes. In conclusion, we have identified the
clathrin pathway as the internalization route for Kv1.5 channel, in atrial
myocytes. Future work will be conducted to further investigate dynamic
and fate of this atria-specific channel. This study should help under-
standing the constitution of the sub-membrane reservoir of repolarization
that we previously described. 
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Cardiac sodium channel is a complex which includes the pore-
forming alpha subunit and regulatory proteins that allow sodium influx
during the depolarization phase of the ventricular action potential. The
alpha subunit, Nav1.5, is encoded by SCN5A. Mutations in this gene are
responsible for a wide spectrum of hereditary arrhythmias such as car-
diac conduction disease and atrial fibrillation. A mutation in SCN5A,
leading to a p.I141V substitution, was identified in a large multigenera-
tional family with an arrhythmia syndrome resembling catecholaminergic
polymorphic ventricular tachycardia through whole-exome sequencing.
The purpose of this study was to identify the molecular mechanisms
linking the p.I141V mutation to this arrhythmia. To evaluate the inci-
dence of this substitution on Nav1.5 function, whole-cell patch-clamp
experiments were performed on HEK293 cells transfected with the
human alpha and beta subunits. The presence of the p.I141V mutation
